Roger Paredes-Deiros
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial.
Journal: Nature communications
Published: April 27, 2026
Exploring potential associations between the human microbiota and reservoir of latent HIV.
Journal: Retrovirology
Published: September 06, 2024
Forecasting readmission in COVID-19 patients utilizing blood biomarkers and machine learning in the Hospital-at-Home program.
Journal: Frontiers in medicine
Published: July 23, 2024
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
Journal: Infectious diseases and therapy
Published: December 09, 2022
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Journal: NPJ biofilms and microbiomes
Published: August 25, 2022
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control.
Journal: Microbiome
Published: June 18, 2021
Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource Savings.
Journal: International journal of environmental research and public health
Published: May 03, 2021
Evolution of the gut microbiome following acute HIV-1 infection.
Journal: Microbiome
Published: December 17, 2018
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Journal: Mucosal immunology
Published: May 17, 2018
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes.
Journal: The Journal of infectious diseases
Published: May 21, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026